Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] | affects binding|decreases reaction|increases chemical synthesis | 16849647
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mRNA] | affects binding|decreases reaction|increases expression | 16849647
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of ABL1 mRNA | increases expression | 16788091
|
C498826 |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] | affects binding|decreases reaction|increases chemical synthesis | 16849647
|
C498826 |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mRNA] | affects binding|decreases reaction|increases expression | 16849647
|
C498826 |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide results in decreased activity of ABL1 protein | decreases activity | 18632630
|
D000079 |
Acetaldehyde |
ABL1 protein promotes the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein] | decreases activity|increases phosphorylation|increases reaction | 17030193
|
D000079 |
Acetaldehyde |
Acetaldehyde results in increased activity of ABL1 protein | increases activity | 17030193
|
D000079 |
Acetaldehyde |
imatinib inhibits the reaction [Acetaldehyde results in increased activity of ABL1 protein] | decreases reaction|increases activity | 17030193
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ABL1 mRNA | affects expression | 17562736
|
D000638 |
Amiodarone |
Amiodarone results in increased expression of ABL1 mRNA | increases expression | 19774075
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of ABL1 protein | increases expression | 16483693
|
C058317 |
arsenic disulfide |
arsenic disulfide results in decreased activity of ABL1 protein | decreases activity | 12421474
|
C058317 |
arsenic disulfide |
arsenic disulfide results in decreased expression of and results in decreased activity of ABL1 protein mutant form | decreases activity|decreases expression | 12421474
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ABL1 mRNA | decreases expression | 20458559
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ABL1 protein mutant form | decreases expression | 14633726
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABL1 mRNA | decreases expression | 19150397
|
C471992 |
bosutinib |
bosutinib results in decreased activity of ABL1 protein | decreases activity | 17114238
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased phosphorylation of ABL1 protein | increases phosphorylation | 17030193
|
D002251 |
Carbon Tetrachloride |
imatinib inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of ABL1 protein] | decreases reaction|increases phosphorylation | 17030193
|
D003042 |
Cocaine |
Cocaine affects the expression of ABL1 mRNA | affects expression | 15681117
|
C488369 |
dasatinib |
dasatinib results in decreased activity of ABL1 protein | decreases activity | 17114238
|
D004967 |
Estrogens |
ABL1 protein results in increased susceptibility to Estrogens | increases response to substance | 20234815
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of ABL1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ABL1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABL1 mRNA | affects cotreatment|increases expression | 17942748
|
D006632 |
Histamine |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] | affects binding|decreases reaction|increases chemical synthesis | 16849647
|
D006632 |
Histamine |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] | affects binding|decreases reaction|increases chemical synthesis | 16849647
|
D006632 |
Histamine |
[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine | affects binding|increases chemical synthesis | 16849647
|
D006632 |
Histamine |
imatinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] | affects binding|decreases reaction|increases chemical synthesis | 16849647
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased activity of ABL1 protein | increases activity | 17030193
|
D006861 |
Hydrogen Peroxide |
imatinib inhibits the reaction [Hydrogen Peroxide results in increased activity of ABL1 protein] | decreases reaction|increases activity | 17030193
|
C097613 |
imatinib |
imatinib results in decreased phosphorylation of ABL1 protein | decreases phosphorylation | 12032135
|
C097613 |
imatinib |
ABL1 mutant form results in increased susceptibility to imatinib | increases response to substance | 15107311
|
C097613 |
imatinib |
imatinib inhibits the reaction [Acetaldehyde results in increased activity of ABL1 protein] | decreases reaction|increases activity | 17030193
|
C097613 |
imatinib |
imatinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] | affects binding|decreases reaction|increases chemical synthesis | 16849647
|
C097613 |
imatinib |
imatinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mRNA] | affects binding|decreases reaction|increases expression | 16849647
|
C097613 |
imatinib |
imatinib inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of ABL1 protein] | decreases reaction|increases phosphorylation | 17030193
|
C097613 |
imatinib |
imatinib inhibits the reaction [Hydrogen Peroxide results in increased activity of ABL1 protein] | decreases reaction|increases activity | 17030193
|
C097613 |
imatinib |
imatinib results in decreased activity of ABL1 protein mutant form | decreases activity | 15329907
|
C097613 |
imatinib |
imatinib results in decreased phosphorylation of ABL1 protein | decreases phosphorylation | 12032135
|
C097613 |
imatinib |
imatinib analog results in decreased activity of ABL1 protein modified form | decreases activity | 15501042
|
C097613 |
imatinib |
imatinib results in decreased activity of ABL1 protein | decreases activity | 16940797
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of ABL1 mRNA | increases expression | 12057914
|
C013592 |
mangiferin |
mangiferin results in decreased expression of ABL1 mRNA | decreases expression | 15498116
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] | decreases activity|decreases reaction|increases expression|increases phosphorylation | 17030193
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased methylation of ABL1 promoter | decreases methylation | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ABL1 mRNA | increases expression | 19482888
|
D010656 |
Phenylephrine |
ABL1 protein affects the reaction [Phenylephrine promotes the reaction [BCAR1 protein binds to CRK protein]] | affects binding|affects reaction|increases reaction | 17615370
|
D010656 |
Phenylephrine |
ABL1 protein affects the reaction [Phenylephrine promotes the reaction [CRK protein binds to WASL protein]] | affects binding|affects reaction|increases reaction | 17615370
|
D010656 |
Phenylephrine |
ABL1 protein affects the reaction [Phenylephrine results in increased phosphorylation of BCAR1 protein] | affects reaction|increases phosphorylation | 17615370
|
D010656 |
Phenylephrine |
ABL1 protein affects the susceptibility to Phenylephrine | affects response to substance | 17615370
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of ABL1 protein | increases phosphorylation | 17615370
|
D011189 |
Potassium Chloride |
ABL1 protein affects the reaction [Potassium Chloride results in increased phosphorylation of BCAR1 protein] | affects reaction|increases phosphorylation | 17615370
|
D011189 |
Potassium Chloride |
ABL1 protein affects the susceptibility to Potassium Chloride | affects response to substance | 17615370
|
D011189 |
Potassium Chloride |
Potassium Chloride results in increased phosphorylation of ABL1 protein | increases phosphorylation | 17615370
|
C487081 |
PXD101 |
PXD101 results in decreased expression of ABL1 mRNA | decreases expression | 19606018
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] | decreases activity|decreases reaction|increases expression|increases phosphorylation | 17030193
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of ABL1 mRNA | increases expression | 12016162
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of ABL1 mRNA | decreases expression | 16014739
|
D013629 |
Tamoxifen |
ABL1 protein results in decreased susceptibility to Tamoxifen | decreases response to substance | 20234815
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ABL1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABL1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ABL1 mRNA | increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ABL1 mRNA | increases expression | 16788091
|
C012589 |
trichostatin A |
trichostatin A results in decreased expression of ABL1 mRNA | decreases expression | 19606018
|
D015032 |
Zinc |
Zinc affects the expression of ABL1 protein | affects expression | 16636310
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.22 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.22 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.22 | 14514962 11752688 15322242 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
4.96 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
5.88 | 18322153 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.23 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.61 | 17505938 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.08 | 16889938 17190629 17202136 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.73 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
marker/mechanism |
|
| 21472143 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
3.99 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.99 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
9.00 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.00 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.37 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.57 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.36 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.68 | 16410023 17119284 16580781 16325427 |
MESH:D000707 |
Anaphylaxis |
|
mangiferin |
5.15 | 14669257 16536907 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.67 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.59 | 16916123 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.51 | 10982225 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
8.21 | 18057881 20041841 18218290 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
8.21 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.15 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.54 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.54 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.19 | 16292516 |
MESH:D001249 |
Asthma |
|
Acetaldehyde |
10.55 | 9600491 |
MESH:D001249 |
Asthma |
|
Histamine |
10.55 | 16387687 |
MESH:D001249 |
Asthma |
|
Tretinoin |
10.55 | 16456186 |
MESH:D001249 |
Asthma |
|
Zinc |
10.55 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
mangiferin |
3.91 | 18450471 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.66 | 18651412 19698954 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.45 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.09 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
19.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
19.59 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
19.59 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
19.59 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.46 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.56 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
5.02 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
mangiferin |
4.63 | 9881647 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.22 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.37 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20234815 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
1.95 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.95 | 19066611 20390343 20065188 19059307 20135344 19200415 19155303 21152245 16818667 17261762 18425577 19244106 18984771 19103187 18351453 16273361 18629630 19288272 18821012 20859285 19289846 20005174 17242785 20544844 11161223 17893378 18997820 19410462 18855134 19189210 15668708 17049068 19189212 19142967 16873071 21138602 19084267 19011961 19221464 17440819 19487384 15565566 16202921 18815881 19115204 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.95 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.95 | 16166294 16443354 16873071 |
MESH:D001986 |
Bronchial Spasm |
|
Histamine |
5.49 | 18298128 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.26 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.03 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.46 | 16124888 16227642 16097048 15721981 10355542 16192424 3786805 15700767 18705752 15673190 16011737 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.55 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.19 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.83 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
15.89 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.89 | 11135700 15073043 15553829 14691202 16217749 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
15.89 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
15.89 | 15341023 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
15.89 | 1701930 6705139 20007298 17173139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
15.89 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
15.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
15.89 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.54 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.84 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.03 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.03 | 16051514 16096774 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
7.03 | 16543248 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.33 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.28 | 11754973 15728586 17287366 16170337 11179087 17124262 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.28 | 18670907 18850075 16120746 |
MESH:D002310 |
Cardiomyopathy, Alcoholic |
|
Acetaldehyde |
6.15 | 10525098 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.78 | 15710769 19225199 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.91 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
6.91 | 16936243 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.76 | 18974383 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.59 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.59 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
5.99 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
5.99 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.93 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.26 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.64 | 17681005 17110522 16919318 15861022 16105132 17333356 11677210 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.83 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.30 | 15668235 8697196 12621046 16354765 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.30 | 9407595 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.39 | 19606084 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.39 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.85 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.79 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.88 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.92 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
6.92 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.92 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.92 | 9664655 10589399 9125849 17551590 8800419 16925845 14991402 9224671 9142499 9211117 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
6.92 | 19302082 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
5.62 | 16670151 |
MESH:D003457 |
Cryptosporidiosis |
|
mangiferin |
5.53 | 16547730 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.80 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.04 | 19031437 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.93 | 16479319 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
mangiferin |
4.33 | 12093613 19028559 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
mangiferin |
4.40 | 9881663 11315760 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.40 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
mangiferin |
8.44 | 19706694 19960420 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.44 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.10 | 10774834 11743745 16109766 12705907 15619225 17906064 17522070 11461765 19420014 18713872 12958197 19416960 16177239 10915739 11421492 11739529 19085960 19739265 11834606 14725611 14986274 18071297 15968718 11287661 16227642 16081117 12540782 16781746 11529661 16393943 2444490 10663392 17562736 19923254 12594235 19370779 16485898 14550746 12153990 12392966 19164858 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
8.10 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.10 | 2869522 6884620 10092053 3732212 10915739 7120509 15027814 7179309 21278145 6623471 15968718 15998439 9327722 3786805 11566570 4309450 16177239 19336974 7440962 19085960 16227642 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.10 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.77 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.52 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.70 | 1851702 |
MESH:D004487 |
Edema |
|
imatinib |
6.28 | 19703484 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.28 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.84 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.84 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.92 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.92 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.31 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.73 | 17893378 19155303 20544844 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.73 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.74 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.07 | 17637181 15821434 15328337 |
MESH:D004802 |
Eosinophilia |
|
Histamine |
4.73 | 12689652 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.79 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.54 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.72 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.27 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.93 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.69 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
marker/mechanism |
|
| 21472143 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.79 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.79 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
6.79 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.04 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.04 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
26.95 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
26.95 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
26.95 | 19224547 16239168 12795759 15959796 12631006 16045604 61145 17595544 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
26.95 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
mangiferin |
26.95 | 15975614 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
26.95 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.04 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.14 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.73 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.20 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
10.74 | 17453242 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.74 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
12.92 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.92 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.92 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.95 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
10.06 | 16983495 |
MESH:D005756 |
Gastritis |
|
Zinc |
10.06 | 17241300 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.35 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.72 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
6.72 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.26 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.75 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.97 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.83 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.96 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.96 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
mangiferin |
4.17 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.41 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.44 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.23 | 17241300 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.10 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.05 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.29 | 19900420 19110552 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.37 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
12.64 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.64 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.64 | 16120746 15340226 12621046 |
MESH:D006561 |
Herpes Simplex |
|
mangiferin |
4.68 | 10715843 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.89 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.71 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.78 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.78 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.21 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.58 | 8137927 9751232 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.25 | 16778211 |
MESH:D006946 |
Hyperinsulinism |
|
mangiferin |
4.73 | 9881663 11315760 |
MESH:D006949 |
Hyperlipidemias |
|
mangiferin |
4.55 | 15975614 |
MESH:D006967 |
Hypersensitivity |
|
mangiferin |
4.41 | 16536907 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
4.88 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.88 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.77 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.26 | 12791704 18502941 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.49 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.20 | 18020914 17991464 |
MESH:D007154 |
Immune System Diseases |
|
mangiferin |
5.53 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.16 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.92 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.92 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
10.61 | 17255318 12878042 17963957 17237260 9205823 |
MESH:D007249 |
Inflammation |
|
mangiferin |
10.61 | 15222974 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.61 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.61 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
mangiferin |
4.13 | 11315760 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.45 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.33 | 17255318 |
MESH:D007511 |
Ischemia |
|
mangiferin |
10.17 | 16806951 |
MESH:D007511 |
Ischemia |
|
Zinc |
10.17 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.97 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.97 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
12.97 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
mangiferin |
12.97 | 12093613 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.97 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
12.97 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
9.26 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
9.26 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.79 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
mangiferin |
4.64 | 19182383 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
9.64 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
9.64 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.64 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.51 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
10.64 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
10.64 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic disulfide |
18.19 | 12421474 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
18.19 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
18.19 | 15748426 17301526 15107311 19208803 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
mangiferin |
18.19 | 15498116 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
14.47 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
14.47 | 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.47 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.83 | 16467208 17050201 16968895 20471514 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.83 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
5.83 | 18206229 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.93 | 17712046 11468182 17649720 17107899 15622746 19642359 16823087 19035177 9834237 16112521 17869043 12018890 16891316 11161223 12679006 17217047 19075265 16331271 15213294 15748426 12712474 15336539 19225113 16966277 16330433 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.93 | 17361223 17506722 19075265 16331271 17301526 16766008 16788101 17368321 19225113 17217047 16935935 15748426 16823087 12679006 16891316 19642359 19029980 19035177 17339181 16140955 17294898 9834237 17649720 17712046 17107899 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.04 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.37 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.08 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
7.15 | 17567588 15342952 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
7.15 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.03 | 16239168 17174718 16221502 21278145 11903743 17334410 17157831 11408273 16943688 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.03 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.15 | 12958196 16033810 16116963 16638106 18395914 15650968 15123356 11481614 12898905 17900296 15362042 15959796 17640975 18472094 15338365 17869086 18412020 17976157 18339082 14716833 17944888 18166357 17557913 16136751 12546737 17922224 12632514 17481882 17721639 16011737 15057751 12649538 18187930 18263696 15996030 14724832 16248980 18420326 17631135 16097048 13678700 20821823 16192424 18054572 15730626 18481824 17525996 12445418 17805973 15931870 18418968 12609069 12667390 15052691 18429990 15893842 18317297 18395095 18156304 18251166 12445421 17708605 18279442 18472332 12632512 14716496 10355542 18006644 15673190 14620537 17766677 17761835 15876570 15818738 12586293 15925388 18210741 17698563 12741479 12389079 17565644 14748882 18205269 16015684 16027843 14512876 18705752 15370692 17714472 12666154 17823541 18376398 18277467 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
8.15 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
8.15 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.15 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.15 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.15 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
5.94 | 16611625 12969438 11587558 19784758 19014921 12587719 19460945 16610002 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.94 | 16964402 15830285 16246199 15720792 17285989 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
5.94 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.85 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.47 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.47 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
16.29 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
16.29 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
16.29 | 8742319 19073162 19482888 21047994 19812893 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
16.29 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
16.29 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.29 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
12.44 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
12.44 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
12.44 | 1399818 6150874 2563599 17172636 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.44 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
7.38 | 17391786 15350150 11989578 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
7.38 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
6.79 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.79 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.15 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.69 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Acetaldehyde |
7.98 | 17372256 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
7.98 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
mangiferin |
7.98 | 18520028 18569708 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
7.98 | 16712894 17077188 19931552 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
7.98 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.98 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.44 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.55 | 14580682 16827153 11731420 19196723 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
5.55 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.22 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.65 | 17453147 |
MESH:D008545 |
Melanoma |
|
Histamine |
9.13 | 17709802 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.13 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.13 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.13 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
9.13 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.86 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.25 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
mangiferin |
4.62 | 19182383 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.11 | 16940565 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
6.80 | 15949261 14977855 19417148 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
6.80 | 18172295 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.57 | 17974566 12754197 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.34 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.77 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.77 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
6.25 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
mangiferin |
6.25 | 16584858 17052832 16697266 19172585 16538859 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.76 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.15 | 17484760 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.65 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
5.81 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.81 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.41 | 19410462 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.57 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
4.57 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.35 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
10.08 | 17614352 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
10.08 | 19200415 19196722 19189210 |
MESH:D009410 |
Nerve Degeneration |
|
mangiferin |
4.37 | 17433543 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.48 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.48 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
10.93 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.93 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.93 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.61 | 18514411 |
MESH:D010014 |
Osteolysis |
|
imatinib |
5.41 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.04 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
13.84 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
13.84 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
13.84 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
13.84 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
13.84 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.73 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.73 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
11.35 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
11.35 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.35 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
11.35 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.39 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.77 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.86 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
mangiferin |
3.59 | 17433543 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.92 | 12520081 |
MESH:D010518 |
Periodontitis |
|
mangiferin |
5.27 | 19026997 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.23 | 12224865 11605937 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.25 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.35 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
4.30 | 12476293 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.93 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.87 | 11222880 11896295 11399792 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
4.93 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.91 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.91 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.91 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
1.91 | 19789329 18798265 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
1.91 | 12429649 16700911 16606632 16517595 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.31 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.99 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.16 | 12752131 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
4.59 | 16134406 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.47 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.73 | 11597910 12490602 12832656 |
MESH:D011833 |
Radiation Injuries, Experimental |
|
mangiferin |
6.08 | 15830843 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.52 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.53 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.89 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.80 | 16116481 16283617 |
MESH:D012220 |
Rhinitis |
|
Acetaldehyde |
8.65 | 17050345 |
MESH:D012220 |
Rhinitis |
|
Histamine |
8.65 | 12689652 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.65 | 16646077 |
MESH:D012640 |
Seizures |
|
Cocaine |
5.75 | 10454489 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.75 | 4039156 16876388 3137016 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.50 | 6407741 |
MESH:D012772 |
Shock, Septic |
|
mangiferin |
4.91 | 15177305 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.76 | 18724381 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.38 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
12.28 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.28 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.28 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
12.28 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.46 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.46 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.71 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.55 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.37 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
3.37 | 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.37 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
6.81 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
mangiferin |
6.81 | 17918041 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.98 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.88 | 19225199 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.88 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.32 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.88 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
10.95 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
10.95 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
15.16 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
15.16 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
15.16 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.16 | 17045167 16026305 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.54 | 19584973 18020914 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.04 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
9.04 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
9.18 | 17467628 11989578 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
9.18 | 15213294 |
MESH:D014235 |
Trichinellosis |
|
mangiferin |
5.73 | 14669257 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.03 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
7.57 | 11780464 20435036 12845720 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.57 | 17306315 16712894 11723127 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.57 | 17572228 8653321 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
8.13 | 10982225 |
MESH:D014581 |
Urticaria |
|
Histamine |
8.13 | 18298128 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.48 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.48 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.99 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.28 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.10 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.26 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.25 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.75 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.92 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.69 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
4.48 | 11172683 |